Greenspan J S, Antunes M J, Holt W J, McElwee D, Cullen J A, Spitzer A R
Department of Pediatrics, Thomas Jefferson Medical College and Hospital, Philadelphia, Pennsylvania, USA.
Pediatr Pulmonol. 1997 Jan;23(1):31-8. doi: 10.1002/(sici)1099-0496(199701)23:1<31::aid-ppul4>3.0.co;2-s.
The decision to place an infant on extracorporeal membrane oxygenation (ECMO) is based on predictions of expected morbidity and mortality. One unknown factor is the relationship between pre-ECMO pulmonary dysfunction and on barotrauma and post-ECMO pulmonary sequelae. To determine whether placement of infants on extracorporeal membrane oxygenation (ECMO) early is associated with less subsequent pulmonary dysfunction than placing infants on EMCO later, we evaluated pulmonary function in 25 neonates prior to ECMO, when the infants had come off EMCO, and at the time of nursery discharge. Pulmonary resistance (R) and compliance (CL) were determined by a pneumotachograph and esophageal manometry, and functional residual capacity (FRC) was determined by a helium dilution method. Maximal expiratory flow (VmaxFRC) was determined by thoracic compression at the time of discharge. Infants were assigned to an early ECMO group (< 36 hours of age, n = 12), or a late ECMO group (> 36 hours of age, n = 13). When first evaluated, the early group had a higher oxygenation index than the late group (mean value, 63 versus 48), but initial pulmonary function measurements were not different between the two groups. In the early group mean CL increase from 0.20 to 0.36 ml/cmH2O/kg, FRC increased from 7 to 20 ml/kg, and mean R decreased from 107 to 61 cmH2O/L/sec between the initial study and immediately after ECMO. In the late group, only FRC increased from a mean of 8 to 20 ml/kg. CL and FRC increased from post-ECMO to discharge in both groups (mean CL from 0.36 to 0.76 ml/cmH2O/kg in the early group, and from 0.30 to 0.79 in the late group). Mean FRC increased from 20 to 26 ml/kg in the early group, and from 20 to 25 ml/kg in the late group. VmaxFRC was lower in the late than the early group at discharge (mean, 1.14 versus 1.58 L/sec; P < 0.05). While both groups of infants had minimal pulmonary dysfunction at discharge, the infants placed on ECMO early had evidence of slightly less airway dysfunction despite a higher initial oxygenation index than the infants placed on ECMO late.
决定对婴儿进行体外膜肺氧合(ECMO)治疗是基于对预期发病率和死亡率的预测。一个未知因素是ECMO治疗前的肺功能障碍与气压伤和ECMO治疗后肺部后遗症之间的关系。为了确定早期对婴儿进行体外膜肺氧合(ECMO)治疗是否比晚期进行ECMO治疗后肺部功能障碍更少,我们评估了25例新生儿在ECMO治疗前、脱离ECMO时以及出院时的肺功能。肺阻力(R)和顺应性(CL)通过呼吸流速仪和食管测压法测定,功能残气量(FRC)通过氦稀释法测定。出院时通过胸部按压测定最大呼气流量(VmaxFRC)。婴儿被分为早期ECMO组(年龄<36小时,n = 12)或晚期ECMO组(年龄>36小时,n = 13)。首次评估时,早期组的氧合指数高于晚期组(平均值,63对48),但两组的初始肺功能测量结果无差异。早期组在初始研究至ECMO治疗后即刻,平均CL从0.20增加至0.36 ml/cmH2O/kg,FRC从7增加至20 ml/kg,平均R从107降至61 cmH2O/L/sec。晚期组仅FRC从平均8增加至20 ml/kg。两组从ECMO治疗后至出院时CL和FRC均增加(早期组平均CL从0.36增加至0.76 ml/cmH2O/kg,晚期组从0.30增加至0.79)。早期组平均FRC从20增加至26 ml/kg,晚期组从20增加至25 ml/kg。出院时晚期组的VmaxFRC低于早期组(平均值,1.14对1.58 L/sec;P<0.05)。虽然两组婴儿出院时肺部功能障碍均最小,但早期接受ECMO治疗的婴儿尽管初始氧合指数高于晚期接受ECMO治疗的婴儿,但气道功能障碍略少。